nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.029	0.534	CbGdCrCtD
Melphalan—Ulcer—Triamcinolone—ankylosing spondylitis	0.00585	0.00618	CcSEcCtD
Melphalan—Extravasation—Betamethasone—ankylosing spondylitis	0.00575	0.00608	CcSEcCtD
Melphalan—Extravasation—Dexamethasone—ankylosing spondylitis	0.00575	0.00608	CcSEcCtD
Melphalan—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00571	0.00604	CcSEcCtD
Melphalan—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00571	0.00604	CcSEcCtD
Melphalan—Vasculitis—Triamcinolone—ankylosing spondylitis	0.00567	0.00599	CcSEcCtD
Melphalan—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.00565	0.00598	CcSEcCtD
Melphalan—Neuropathy—Prednisolone—ankylosing spondylitis	0.00565	0.00597	CcSEcCtD
Melphalan—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.00541	0.00572	CcSEcCtD
Melphalan—Liver disorder—Methotrexate—ankylosing spondylitis	0.00536	0.00567	CcSEcCtD
Melphalan—Ulcer—Betamethasone—ankylosing spondylitis	0.00531	0.00561	CcSEcCtD
Melphalan—Ulcer—Dexamethasone—ankylosing spondylitis	0.00531	0.00561	CcSEcCtD
Melphalan—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.00528	0.00558	CcSEcCtD
Melphalan—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.00527	0.00557	CcSEcCtD
Melphalan—Neuropathy—Triamcinolone—ankylosing spondylitis	0.00519	0.00549	CcSEcCtD
Melphalan—Neuropathy—Methylprednisolone—ankylosing spondylitis	0.00518	0.00548	CcSEcCtD
Melphalan—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.00516	0.00546	CcSEcCtD
Melphalan—Vasculitis—Betamethasone—ankylosing spondylitis	0.00514	0.00544	CcSEcCtD
Melphalan—Vasculitis—Dexamethasone—ankylosing spondylitis	0.00514	0.00544	CcSEcCtD
Melphalan—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00497	0.00526	CcSEcCtD
Melphalan—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.00479	0.00507	CcSEcCtD
Melphalan—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.00479	0.00507	CcSEcCtD
Melphalan—Neuropathy—Dexamethasone—ankylosing spondylitis	0.00471	0.00498	CcSEcCtD
Melphalan—Neuropathy—Betamethasone—ankylosing spondylitis	0.00471	0.00498	CcSEcCtD
Melphalan—Skin ulcer—Methotrexate—ankylosing spondylitis	0.00469	0.00496	CcSEcCtD
Melphalan—Ulcer—Prednisone—ankylosing spondylitis	0.00462	0.00489	CcSEcCtD
Melphalan—Vasculitis—Prednisone—ankylosing spondylitis	0.00448	0.00474	CcSEcCtD
Melphalan—SLC7A5—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00441	0.0812	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00434	0.08	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00434	0.08	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00424	0.0781	CbGdCrCtD
Melphalan—Extravasation—Methotrexate—ankylosing spondylitis	0.00419	0.00443	CcSEcCtD
Melphalan—Skin exfoliation—Prednisone—ankylosing spondylitis	0.00417	0.00441	CcSEcCtD
Melphalan—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00415	0.00439	CcSEcCtD
Melphalan—Neuropathy—Prednisone—ankylosing spondylitis	0.0041	0.00434	CcSEcCtD
Melphalan—SLC7A5—Desoximetasone—Prednisone—ankylosing spondylitis	0.00403	0.0741	CbGdCrCtD
Melphalan—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.00394	0.00416	CcSEcCtD
Melphalan—SLC7A5—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00393	0.0724	CbGdCrCtD
Melphalan—Ulcer—Methotrexate—ankylosing spondylitis	0.00386	0.00408	CcSEcCtD
Melphalan—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00382	0.00404	CcSEcCtD
Melphalan—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00381	0.00403	CcSEcCtD
Melphalan—Vasculitis—Methotrexate—ankylosing spondylitis	0.00374	0.00396	CcSEcCtD
Melphalan—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.00372	0.00393	CcSEcCtD
Melphalan—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.00357	0.00377	CcSEcCtD
Melphalan—Cystitis—Methotrexate—ankylosing spondylitis	0.00353	0.00373	CcSEcCtD
Melphalan—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.00349	0.00369	CcSEcCtD
Melphalan—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00346	0.00366	CcSEcCtD
Melphalan—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00346	0.00366	CcSEcCtD
Melphalan—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00341	0.0036	CcSEcCtD
Melphalan—Bladder pain—Methotrexate—ankylosing spondylitis	0.0033	0.00349	CcSEcCtD
Melphalan—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.0033	0.00349	CcSEcCtD
Melphalan—Neoplasm—Methotrexate—ankylosing spondylitis	0.0033	0.00349	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.0033	0.00349	CcSEcCtD
Melphalan—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00304	0.00321	CcSEcCtD
Melphalan—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00303	0.00321	CcSEcCtD
Melphalan—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00303	0.0032	CcSEcCtD
Melphalan—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00302	0.00319	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00302	0.00319	CcSEcCtD
Melphalan—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00287	0.00304	CcSEcCtD
Melphalan—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00279	0.00295	CcSEcCtD
Melphalan—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00279	0.00295	CcSEcCtD
Melphalan—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00278	0.00294	CcSEcCtD
Melphalan—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00277	0.00293	CcSEcCtD
Melphalan—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00275	0.00291	CcSEcCtD
Melphalan—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00275	0.00291	CcSEcCtD
Melphalan—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00272	0.00288	CcSEcCtD
Melphalan—Arrhythmia—Prednisolone—ankylosing spondylitis	0.0027	0.00285	CcSEcCtD
Melphalan—Neutropenia—Prednisone—ankylosing spondylitis	0.00256	0.00271	CcSEcCtD
Melphalan—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00253	0.00268	CcSEcCtD
Melphalan—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00253	0.00268	CcSEcCtD
Melphalan—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00252	0.00267	CcSEcCtD
Melphalan—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00252	0.00267	CcSEcCtD
Melphalan—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0025	0.00265	CcSEcCtD
Melphalan—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0025	0.00264	CcSEcCtD
Melphalan—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00248	0.00262	CcSEcCtD
Melphalan—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00248	0.00262	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00245	0.00259	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.0024	0.00253	CcSEcCtD
Melphalan—Convulsion—Prednisolone—ankylosing spondylitis	0.00228	0.00241	CcSEcCtD
Melphalan—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00225	0.00238	CcSEcCtD
Melphalan—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00225	0.00238	CcSEcCtD
Melphalan—Alopecia—Betamethasone—ankylosing spondylitis	0.00223	0.00236	CcSEcCtD
Melphalan—Alopecia—Dexamethasone—ankylosing spondylitis	0.00223	0.00236	CcSEcCtD
Melphalan—Haemoglobin—Prednisone—ankylosing spondylitis	0.00221	0.00233	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—ankylosing spondylitis	0.00219	0.00232	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00218	0.0023	CcSEcCtD
Melphalan—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00216	0.00228	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00215	0.00227	CcSEcCtD
Melphalan—Oedema—Prednisolone—ankylosing spondylitis	0.00215	0.00227	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—ankylosing spondylitis	0.00214	0.00227	CcSEcCtD
Melphalan—Cough—Triamcinolone—ankylosing spondylitis	0.00211	0.00223	CcSEcCtD
Melphalan—Convulsion—Triamcinolone—ankylosing spondylitis	0.0021	0.00222	CcSEcCtD
Melphalan—Tachycardia—Prednisolone—ankylosing spondylitis	0.00209	0.00221	CcSEcCtD
Melphalan—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00209	0.00221	CcSEcCtD
Melphalan—Myalgia—Triamcinolone—ankylosing spondylitis	0.00206	0.00218	CcSEcCtD
Melphalan—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00205	0.00217	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00204	0.00216	CcSEcCtD
Melphalan—Flushing—Prednisone—ankylosing spondylitis	0.00204	0.00215	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—ankylosing spondylitis	0.00199	0.00211	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—ankylosing spondylitis	0.00198	0.0021	CcSEcCtD
Melphalan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00197	0.00209	CcSEcCtD
Melphalan—Oedema—Triamcinolone—ankylosing spondylitis	0.00197	0.00209	CcSEcCtD
Melphalan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00197	0.00208	CcSEcCtD
Melphalan—Arrhythmia—Prednisone—ankylosing spondylitis	0.00196	0.00207	CcSEcCtD
Melphalan—Infection—Triamcinolone—ankylosing spondylitis	0.00196	0.00207	CcSEcCtD
Melphalan—Infection—Methylprednisolone—ankylosing spondylitis	0.00196	0.00207	CcSEcCtD
Melphalan—Alopecia—Prednisone—ankylosing spondylitis	0.00194	0.00205	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00193	0.00204	CcSEcCtD
Melphalan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00193	0.00204	CcSEcCtD
Melphalan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00193	0.00204	CcSEcCtD
Melphalan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00192	0.00203	CcSEcCtD
Melphalan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00191	0.00202	CcSEcCtD
Melphalan—Convulsion—Dexamethasone—ankylosing spondylitis	0.0019	0.00201	CcSEcCtD
Melphalan—Convulsion—Betamethasone—ankylosing spondylitis	0.0019	0.00201	CcSEcCtD
Melphalan—Myalgia—Betamethasone—ankylosing spondylitis	0.00187	0.00198	CcSEcCtD
Melphalan—Myalgia—Dexamethasone—ankylosing spondylitis	0.00187	0.00198	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00184	0.00195	CcSEcCtD
Melphalan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00184	0.00195	CcSEcCtD
Melphalan—Pain—Prednisolone—ankylosing spondylitis	0.00184	0.00194	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00183	0.00194	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—ankylosing spondylitis	0.00183	0.00194	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00181	0.00192	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0019	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0018	0.0019	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00179	0.0019	CcSEcCtD
Melphalan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00179	0.00189	CcSEcCtD
Melphalan—Oedema—Dexamethasone—ankylosing spondylitis	0.00179	0.00189	CcSEcCtD
Melphalan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00179	0.00189	CcSEcCtD
Melphalan—Oedema—Betamethasone—ankylosing spondylitis	0.00179	0.00189	CcSEcCtD
Melphalan—Infection—Betamethasone—ankylosing spondylitis	0.00178	0.00188	CcSEcCtD
Melphalan—Infection—Dexamethasone—ankylosing spondylitis	0.00178	0.00188	CcSEcCtD
Melphalan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00177	0.00187	CcSEcCtD
Melphalan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00177	0.00187	CcSEcCtD
Melphalan—Anaemia—Prednisone—ankylosing spondylitis	0.00177	0.00187	CcSEcCtD
Melphalan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00176	0.00186	CcSEcCtD
Melphalan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00175	0.00185	CcSEcCtD
Melphalan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00175	0.00185	CcSEcCtD
Melphalan—Tachycardia—Betamethasone—ankylosing spondylitis	0.00175	0.00185	CcSEcCtD
Melphalan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00175	0.00185	CcSEcCtD
Melphalan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00174	0.00184	CcSEcCtD
Melphalan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00173	0.00183	CcSEcCtD
Melphalan—Anorexia—Dexamethasone—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Melphalan—Anorexia—Betamethasone—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Melphalan—Urticaria—Prednisolone—ankylosing spondylitis	0.0017	0.0018	CcSEcCtD
Melphalan—Fatigue—Triamcinolone—ankylosing spondylitis	0.0017	0.0018	CcSEcCtD
Melphalan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0017	0.0018	CcSEcCtD
Melphalan—Pain—Triamcinolone—ankylosing spondylitis	0.00169	0.00178	CcSEcCtD
Melphalan—Hypotension—Dexamethasone—ankylosing spondylitis	0.00167	0.00177	CcSEcCtD
Melphalan—Hypotension—Betamethasone—ankylosing spondylitis	0.00167	0.00177	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Melphalan—Convulsion—Prednisone—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00165	0.00175	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00163	0.00173	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00163	0.00173	CcSEcCtD
Melphalan—Myalgia—Prednisone—ankylosing spondylitis	0.00163	0.00172	CcSEcCtD
Melphalan—Alopecia—Methotrexate—ankylosing spondylitis	0.00162	0.00171	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00162	0.00171	CcSEcCtD
Melphalan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00161	0.0017	CcSEcCtD
Melphalan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00161	0.0017	CcSEcCtD
Melphalan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00158	0.00167	CcSEcCtD
Melphalan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00158	0.00167	CcSEcCtD
Melphalan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00158	0.00167	CcSEcCtD
Melphalan—Urticaria—Triamcinolone—ankylosing spondylitis	0.00157	0.00166	CcSEcCtD
Melphalan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00156	0.00165	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00156	0.00165	CcSEcCtD
Melphalan—Oedema—Prednisone—ankylosing spondylitis	0.00156	0.00165	CcSEcCtD
Melphalan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00156	0.00165	CcSEcCtD
Melphalan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00156	0.00165	CcSEcCtD
Melphalan—Infection—Prednisone—ankylosing spondylitis	0.00155	0.00164	CcSEcCtD
Melphalan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Melphalan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Melphalan—Fatigue—Dexamethasone—ankylosing spondylitis	0.00154	0.00163	CcSEcCtD
Melphalan—Fatigue—Betamethasone—ankylosing spondylitis	0.00154	0.00163	CcSEcCtD
Melphalan—Pain—Dexamethasone—ankylosing spondylitis	0.00153	0.00162	CcSEcCtD
Melphalan—Pain—Betamethasone—ankylosing spondylitis	0.00153	0.00162	CcSEcCtD
Melphalan—Tachycardia—Prednisone—ankylosing spondylitis	0.00152	0.00161	CcSEcCtD
Melphalan—Skin disorder—Prednisone—ankylosing spondylitis	0.00151	0.0016	CcSEcCtD
Melphalan—Anorexia—Prednisone—ankylosing spondylitis	0.00149	0.00157	CcSEcCtD
Melphalan—Anaemia—Methotrexate—ankylosing spondylitis	0.00148	0.00156	CcSEcCtD
Melphalan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00145	0.00154	CcSEcCtD
Melphalan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00145	0.00153	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—ankylosing spondylitis	0.00143	0.00151	CcSEcCtD
Melphalan—Urticaria—Betamethasone—ankylosing spondylitis	0.00142	0.0015	CcSEcCtD
Melphalan—Urticaria—Dexamethasone—ankylosing spondylitis	0.00142	0.0015	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00142	0.0015	CcSEcCtD
Melphalan—Asthenia—Triamcinolone—ankylosing spondylitis	0.00142	0.0015	CcSEcCtD
Melphalan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00141	0.00149	CcSEcCtD
Melphalan—Paraesthesia—Prednisone—ankylosing spondylitis	0.0014	0.00148	CcSEcCtD
Melphalan—Pruritus—Triamcinolone—ankylosing spondylitis	0.0014	0.00148	CcSEcCtD
Melphalan—Cough—Methotrexate—ankylosing spondylitis	0.00139	0.00147	CcSEcCtD
Melphalan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00139	0.00147	CcSEcCtD
Melphalan—Convulsion—Methotrexate—ankylosing spondylitis	0.00138	0.00146	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—ankylosing spondylitis	0.00137	0.00145	CcSEcCtD
Melphalan—Myalgia—Methotrexate—ankylosing spondylitis	0.00136	0.00144	CcSEcCtD
Melphalan—Chest pain—Methotrexate—ankylosing spondylitis	0.00136	0.00144	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—ankylosing spondylitis	0.00136	0.00143	CcSEcCtD
Melphalan—Rash—Prednisolone—ankylosing spondylitis	0.00135	0.00143	CcSEcCtD
Melphalan—Dermatitis—Prednisolone—ankylosing spondylitis	0.00135	0.00143	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00135	0.00143	CcSEcCtD
Melphalan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Melphalan—Fatigue—Prednisone—ankylosing spondylitis	0.00134	0.00142	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0013	0.00138	CcSEcCtD
Melphalan—Infection—Methotrexate—ankylosing spondylitis	0.00129	0.00137	CcSEcCtD
Melphalan—Asthenia—Betamethasone—ankylosing spondylitis	0.00128	0.00136	CcSEcCtD
Melphalan—Asthenia—Dexamethasone—ankylosing spondylitis	0.00128	0.00136	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00128	0.00135	CcSEcCtD
Melphalan—Nausea—Prednisolone—ankylosing spondylitis	0.00127	0.00135	CcSEcCtD
Melphalan—Pruritus—Dexamethasone—ankylosing spondylitis	0.00127	0.00134	CcSEcCtD
Melphalan—Pruritus—Betamethasone—ankylosing spondylitis	0.00127	0.00134	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—ankylosing spondylitis	0.00127	0.00134	CcSEcCtD
Melphalan—Vomiting—Triamcinolone—ankylosing spondylitis	0.00125	0.00133	CcSEcCtD
Melphalan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00125	0.00132	CcSEcCtD
Melphalan—Rash—Triamcinolone—ankylosing spondylitis	0.00124	0.00132	CcSEcCtD
Melphalan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00124	0.00131	CcSEcCtD
Melphalan—Anorexia—Methotrexate—ankylosing spondylitis	0.00124	0.00131	CcSEcCtD
Melphalan—Rash—Methylprednisolone—ankylosing spondylitis	0.00124	0.00131	CcSEcCtD
Melphalan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00124	0.00131	CcSEcCtD
Melphalan—Urticaria—Prednisone—ankylosing spondylitis	0.00124	0.00131	CcSEcCtD
Melphalan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00123	0.0013	CcSEcCtD
Melphalan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00123	0.0013	CcSEcCtD
Melphalan—Hypotension—Methotrexate—ankylosing spondylitis	0.00122	0.00129	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00119	0.00126	CcSEcCtD
Melphalan—Nausea—Triamcinolone—ankylosing spondylitis	0.00117	0.00124	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00117	0.00124	CcSEcCtD
Melphalan—Nausea—Methylprednisolone—ankylosing spondylitis	0.00117	0.00124	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00116	0.00123	CcSEcCtD
Melphalan—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00115	0.00121	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00115	0.00121	CcSEcCtD
Melphalan—Vomiting—Betamethasone—ankylosing spondylitis	0.00114	0.0012	CcSEcCtD
Melphalan—Vomiting—Dexamethasone—ankylosing spondylitis	0.00114	0.0012	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00113	0.0012	CcSEcCtD
Melphalan—Rash—Betamethasone—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Melphalan—Rash—Dexamethasone—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Melphalan—Dermatitis—Betamethasone—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Melphalan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Melphalan—Fatigue—Methotrexate—ankylosing spondylitis	0.00112	0.00119	CcSEcCtD
Melphalan—Asthenia—Prednisone—ankylosing spondylitis	0.00112	0.00118	CcSEcCtD
Melphalan—Pain—Methotrexate—ankylosing spondylitis	0.00111	0.00118	CcSEcCtD
Melphalan—Pruritus—Prednisone—ankylosing spondylitis	0.0011	0.00117	CcSEcCtD
Melphalan—Diarrhoea—Prednisone—ankylosing spondylitis	0.00107	0.00113	CcSEcCtD
Melphalan—Nausea—Betamethasone—ankylosing spondylitis	0.00106	0.00112	CcSEcCtD
Melphalan—Nausea—Dexamethasone—ankylosing spondylitis	0.00106	0.00112	CcSEcCtD
Melphalan—Urticaria—Methotrexate—ankylosing spondylitis	0.00104	0.00109	CcSEcCtD
Melphalan—Vomiting—Prednisone—ankylosing spondylitis	0.000992	0.00105	CcSEcCtD
Melphalan—Rash—Prednisone—ankylosing spondylitis	0.000983	0.00104	CcSEcCtD
Melphalan—Dermatitis—Prednisone—ankylosing spondylitis	0.000982	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00096	0.00102	CcSEcCtD
Melphalan—Asthenia—Methotrexate—ankylosing spondylitis	0.000935	0.000989	CcSEcCtD
Melphalan—Nausea—Prednisone—ankylosing spondylitis	0.000926	0.000979	CcSEcCtD
Melphalan—Pruritus—Methotrexate—ankylosing spondylitis	0.000922	0.000975	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000892	0.000943	CcSEcCtD
Melphalan—Vomiting—Methotrexate—ankylosing spondylitis	0.000829	0.000876	CcSEcCtD
Melphalan—Rash—Methotrexate—ankylosing spondylitis	0.000822	0.000869	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000821	0.000868	CcSEcCtD
Melphalan—Nausea—Methotrexate—ankylosing spondylitis	0.000774	0.000819	CcSEcCtD
